While treatment resistance in schizophrenia is defined as moderate or worse symptoms for more than 12 weeks, a commentary argues that breakthrough psychotic symptoms while receiving antipsychotic maintenance medication should be classified as treatment resistance right away so that clozapine, the only drug approved for treatment resistance, can be initiated. https://t.co/q70lFWHKD5